{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:33Z","timestamp":1707525693448},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,21]]},"DOI":"10.7759\/cureus.52659","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T13:06:46Z","timestamp":1705842406000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Type 1 Cryoglobulinemia With Lymphoplasmacytic Lymphoma and Dry Gangrene"],"prefix":"10.7759","author":[{"given":"Abhinav K","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S","family":"Holladay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Saylors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26082","article-title":"Waldenstr\u00f6m macroglobulinemia: 2021 update on diagnosis, risk stratification, and management","volume":"96","author":"Gertz MA","year":"2021","unstructured":"Gertz MA. Waldenstr\u00f6m macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. Am J Hematol. 2021, 96:258-69. 10.1002\/ajh.26082","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911145","article-title":"Waldenstr\u00f6m macroglobulinemia: mechanisms of disease progression and current therapies","volume":"23","author":"Boutilier AJ","year":"2022","unstructured":"Boutilier AJ, Huang L, Elsawa SF. Waldenstr\u00f6m macroglobulinemia: mechanisms of disease progression and current therapies. Int J Mol Sci. 2022, 23:10.3390\/ijms231911145","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/15347346211026994","article-title":"Acrocyanosis and progressive skin necrosis as manifestation of Waldenstrom macroglobulinemia associated with type I cryoglobulinemia: a case report","volume":"22","author":"Nekooghadam SM","year":"2023","unstructured":"Nekooghadam SM, Bozorgmehr R, Safavi-Naini SA. Acrocyanosis and progressive skin necrosis as manifestation of Waldenstrom macroglobulinemia associated with type I cryoglobulinemia: a case report. Int J Low Extrem Wounds. 2023, 22:605-9. 10.1177\/15347346211026994","journal-title":"Int J Low Extrem Wounds"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier B","year":"2013","unstructured":"Terrier B, Karras A, Kahn JE, et al.. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore). 2013, 92:61-8. 10.1097\/MD.0b013e318288925c","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana S","year":"2017","unstructured":"Sidana S, Rajkumar SV, Dispenzieri A, et al.. Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia. Am J Hematol. 2017, 92:668-73. 10.1002\/ajh.24745","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.1.214","article-title":"Waldenstr\u00f6m's macroglobulinemia: clinical features, complications, and management","volume":"18","author":"Dimopoulos MA","year":"2000","unstructured":"Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M. Waldenstr\u00f6m's macroglobulinemia: clinical features, complications, and management. J Clin Oncol. 2000, 18:214-26. 10.1200\/JCO.2000.18.1.214","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel P","year":"2009","unstructured":"Morel P, Duhamel A, Gobbi P, et al.. International prognostic scoring system for Waldenstrom macroglobulinemia. Blood. 2009, 113:4163-70. 10.1182\/blood-2008-08-174961","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6257-y","article-title":"Gangrenous, hemorrhagic, bullous cellulitis associated with pseudomonas aeruginosa in a patient with Waldenstr\u00f6m's macroglobulinemia","volume":"35","author":"Falagas ME","year":"2007","unstructured":"Falagas ME, Pappas VD, Michalopoulos A. Gangrenous, hemorrhagic, bullous cellulitis associated with pseudomonas aeruginosa in a patient with Waldenstr\u00f6m's macroglobulinemia. Infection. 2007, 35:370-3. 10.1007\/s15010-007-6257-y","journal-title":"Infection"},{"key":"ref9","article-title":"Gangrenous cholecystitis in a patient with Waldenstr\u00f6m's macroglobulinemia","volume":"53","author":"Weinstein EC","year":"1970","unstructured":"Weinstein EC. Gangrenous cholecystitis in a patient with Waldenstr\u00f6m's macroglobulinemia. Int Surg. 1970, 53:179-83.","journal-title":"Int Surg"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.4103\/1658-5127.141999","article-title":"Multiple myeloma presenting as extensive limb gangrene","volume":"5","author":"Abdulla MC","year":"2014","unstructured":"Abdulla MC. Multiple myeloma presenting as extensive limb gangrene. J Applied Hematol. 2014, 5:107.","journal-title":"J Applied Hematol"},{"key":"ref11","article-title":"Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenstr\u00f6m's type","volume":"43","author":"H\u00f6ffkes HG","year":"1995","unstructured":"H\u00f6ffkes HG, Heemann UW, Teschendorf C, Uppenkamp M, Philipp T. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenstr\u00f6m's type. Clin Nephrol. 1995, 43:335-8.","journal-title":"Clin Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.100","article-title":"Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma","volume":"23","author":"Rummel MJ","year":"2005","unstructured":"Rummel MJ, Al-Batran SE, Kim SZ, et al.. Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma. J Clin Oncol. 2005, 23:3383-9. 10.1200\/JCO.2005.08.100","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217543-a-case-of-type-1-cryoglobulinemia-with-lymphoplasmacytic-lymphoma-and-dry-gangrene","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:49Z","timestamp":1707509569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217543-a-case-of-type-1-cryoglobulinemia-with-lymphoplasmacytic-lymphoma-and-dry-gangrene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.52659","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}